Cogniscan was founded with the mission to advance the field of neuroscience research through innovative data acquisition and reduction systems. The company specializes in providing high-precision EEG/ERP systems that support up to 128 channels, utilizing standard PC-based data acquisition interfaces. Their products are designed to streamline the process of data collection and analysis in various EEG/ERP studies, ensuring accurate and efficient research outcomes. The market focus is primarily on academic and clinical researchers who require reliable tools for neuroscience experiments.
Notable affiliated people and investors in Cogniscan have not been publicly disclosed. However, the company has achieved significant milestones in developing software tools that evaluate contact impedance and coordinate experimental actions via a serial interface. These advancements have made a substantial impact on the efficiency and accuracy of neuroscience research, positioning Cogniscan as a valuable contributor to the scientific community.
